Products
By Team
Sales
Multithread effectively and personalize outreach to convert deals faster
Social Media Marketing
Elevate social presence and drive business growth from social media
RevOps
Identify and prioritize high-intent leads, and improve sales effectiveness
Events & Field Marketing
Find and connect with ICP attendees, and improve event outcomes
Resources
.png)
.png)
SEQENS
What Does SEQENS Do?
Seqens is an integrated global leader in pharmaceutical solutions and specialty ingredients. The company develops and produces active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and a wide range of specialty chemicals for industries including pharmaceuticals, cosmetics, electronics, and home care. Seqens is committed to innovation, sustainable development, and customer-centricity, operating a network of R&D centers and manufacturing sites across Europe, North America, and Asia.
Where Is SEQENS's Headquarters?
HQ Function
Serves as the central hub for corporate strategy, global management, R&D program oversight, finance, M&A, and key administrative functions, directing the group's international operations.
Notable Features:
Modern office facilities within the Parc Tertiaire de Lyon Nord, designed to promote collaboration and innovation. Strategically positioned with access to Lyon's rich scientific, academic, and business ecosystem.
Work Culture:
A dynamic, international, and results-oriented environment focused on scientific excellence, operational efficiency, safety, and quality. Emphasizes teamwork, customer satisfaction, and sustainable practices.
HQ Significance:
Centrally located in a key European innovation corridor, the Écully headquarters facilitates strategic decision-making, R&D partnerships, and management of Seqens' global footprint.
Values Reflected in HQ: The headquarters' location and design reflect Seqens' commitment to innovation, global connectivity, professionalism, and sustainable growth within the chemical and pharmaceutical sectors.
Location:
Seqens operates a robust global network comprising 24 industrial sites and 10 R&D centers strategically located across Europe, North America, and Asia. This extensive presence enables Seqens to support its worldwide customer base with comprehensive services including research and development, manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates, production of specialty ingredients, as well as sales, marketing, and integrated supply chain management.
Street Address:
21 chemin de la Sauvegarde, Parc Tertiaire de Lyon Nord
City:
Écully
State/Province:
Auvergne-RhĂ´ne-Alpes
Country:
France
Where Else Does SEQENS Operate Around the World?
Devens, Massachusetts, USA
Address: 33 New Bond St, Devens, MA 01434, USA
Serves as a crucial hub for Seqens' growth in the North American pharmaceutical market, offering localized R&D, production, and commercial support.
Billingham, UK
Address: Belasis Avenue, Billingham, TS23 1LQ, UK
Supports European and global customers with advanced chemical manufacturing capabilities and expertise in complex chemistries, contributing to various industrial supply chains.
Roussillon, Isère, France
Address: Plateforme Chimique OSIRIS, CS 70300, 38550 Le PĂ©age-de-Roussillon, France
Acts as a core European production hub with substantial capacity and technological capabilities, vital for Seqens' supply chain in pharmaceutical and specialty chemical markets.
Jurong Island, Singapore
Address: 12 Sakra Road, Singapore 627891 (Illustrative address on Jurong Island, specific Seqens plot may vary)
Functions as a strategic production and supply center for Southeast Asia and the wider APAC markets, capitalizing on Singapore's logistical strengths and established chemical industry ecosystem.
Buying Intent Signals for SEQENS
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Who's Leading SEQENS? Meet the Executive Team
As of April 2025, SEQENS' leadership includes:
Who's Investing in SEQENS?
SEQENS has been backed by several prominent investors over the years, including:
What Leadership Changes Has SEQENS Seen Recently?
In the last 12 months, Seqens has experienced a key leadership transition with the appointment of Gilles Gauthier as the new Chief Executive Officer in January 2024. This change marks a new phase of strategic development for the company under the ownership of SK Capital Partners. Pierre Luzeau, the former CEO, has transitioned to the role of Chairman.
Departures
New Appointments:
What Technology (Tech Stack) Is Used bySEQENS?
Discover the tools SEQENS uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
SEQENS Email Formats and Examples
Seqens typically utilizes standard corporate email formats. The most common formats observed are first initial followed by last name, or first name separated by a period from the last name, both at the seqens.com domain.
flastname@seqens.com or f.lastname@seqens.com
Format
ggauthier@seqens.com
Example
80%
Success rate
What's the Latest News About SEQENS?
SK Capital Press Release • January 9, 2024
Seqens Appoints Gilles Gauthier as Chief Executive Officer
Seqens announced the appointment of Gilles Gauthier as its new Chief Executive Officer. Gauthier succeeds Pierre Luzeau, who will continue to serve as Chairman of Seqens. This leadership change aims to steer Seqens into its next phase of growth and development....more
Seqens Press Release • December 5, 2023
Seqens to Expand its CDMO R&D Lipid Capabilities with a New Laboratory in Boston, US
Seqens revealed plans to enhance its Contract Development and Manufacturing Organization (CDMO) R&D capabilities by establishing a new laboratory in Boston, Massachusetts. The lab will focus on lipids for drug delivery systems, particularly for mRNA vaccines and therapies....more
Seqens Press Release • October 19, 2023
Seqens and Indah Kiat (Sinar Mas Group) Create Joint Venture for Bio-Based IPA Production in Indonesia
Seqens entered into a joint venture with Indah Kiat, part of Sinar Mas Group, to construct and operate a new production facility for bio-based Isopropyl Alcohol (IPA) in Perawang, Indonesia. This initiative aims to bolster sustainable solvent production and expand Seqens' offerings in eco-friendly chemicals....more
Highperformr's free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including SEQENS, are just a search away.